Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visbiome for Gulf War Illness
NCT03078530Phase 3Unknown
- Start
- Sep 2013
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Visbiome in Gulf War syndrome (GWS) and irritable bowel syndrome (IBS). Status: unknown.
02
Drugs
Visbiome
03
Conditions
Gulf War syndrome (GWS)irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT03078530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078530.